We are pleased to inform everyone there is now an organized and physician backed Joint Registry for those with hip, knee and shoulder implants: www.orthoimplantsite.com The registry site is the first of its kind to promote awareness and information on joint recalls, issues and potential…
Stryker Corporation released its Rejuvenate and ABG II Modular-Neck Hip Stem in 2009, but recalled the device three years later in July 2012. Stryker’s metal-on-metal hip implant began to show evidence of corrosion after devices were implanted. Medical researchers have also voiced concern over the…
The new generation anticoagulant Xarelto is the subject of a wrongful death lawsuit filed last month by the family of a Vermont man who died on August 1, 2012, as a result of a fatal brain hemorrhage.
The U.S. Food and Drug Administration is unleashing a barrage of quality-control initiatives aimed at overseas drug manufacturing, potentially empowering prosecutors who choose to target those companies with sloppy production techniques. The campaign played a large part in FDA Commissioner Margaret
Childers, Schlueter & Smith L.L.C. is proud to announce that firm partner M. Brandon Smith has been listed in the Smith-Best Lawyers 2015 Edition of Best Lawyers®. Best Lawyers® is the oldest and most respected peer-review publication in the legal profession.
Virginia Stuntebeck sued Johnson & Johnson and Bayer AG in Pennsylvania court earlier this year, alleging that she suffered severe internal bleeding stemming from use of the blood-thinning drug Xarelto. In the Xarelto lawsuit, which appears to be the first tort suit filed over the…
Our personal injury lawyers have been investigating claims on behalf of those that have had revision surgeries as a result of metal hip implant complications since the Stryker Rejuvenate modular-neck stem implant recall nearly two years ago. In July 2012, the Stryker Corporation issued a…
Anticoagulants such as Xarelto are considered by many to be among the most dangerous drugs because of the high number of serious side effects that are being reported to the U.S. Food and Drug Administration. Xarelto belongs to a class of anticoagulants called direct factor…
Xarelto, Bayer’s blood thinner formulated to prevent blood clots and lower the risk of stroke, may also cause uncontrolled bleeding that can lead to hospitalization and even death. Xarelto is an anticoagulant developed by Bayer and Johnson & Johnson’s New Jersey-based unit, Janssen Pharmaceuticals.
Since the drug Xarelto (Rivaroxaban) was approved by the U.S. Food and Drug Administration to treat atrial fibrillation, a condition that causes blood to pool in the storage chamber of the heart where it can clot and travel to the brain, there have been over 2,100…
Injured families and families of lost loved ones have filed lawsuits again Fresenius, the German-based manufacturer of GranuFlo and NaturaLyte, chemicals used in dialysis machines to help clean blood. The suits allege that the chemicals sharply increase the risk of cardiopulmonary arrest and sudden
A group of retired NFL players has filed a lawsuit against the league alleging that teams knowingly and illegally supplied players with painkillers and anti-inflammatory drugs to keep them on the field, and held back information regarding the long-term dangers associated with taking the drugs.…
